Check out last month's top stories. If you like what you see, join the STAT+ community today — and enjoy 25% off your first year. Molly Ferguson/STAT Northwest Bio study of brain cancer vaccine still falls short by Adam Feuerstein Read More Mike Reddy for STAT PhRMA, once invincible in Washington, has lost its edge by Rachel Cohrs Read More ADOBE Following your gut: How scientists are getting closer to linking the microbiome and chronic diseases by Isabella Cueto Read More MORE TOP STORIES Unexpected troubles hit large medical billing firm R1 RCM, part-owned by Ascension by Bob Herman Boom and bust: Whose biotech VC assets have grown and shrunk the most? by Allison DeAngelis and Kate Sheridan ‘If this works, it changes everything’: Altos Labs founders lay out plan to reverse disease by Jason Mast ‘We were right all along:’ For Japanese drugmaker Eisai, success against Alzheimer’s has been a long time coming by Adam Feuerstein, Jason Mast, and Damian Garde Former Merck CEO: Democracy and the drug industry are both in danger by Matthew Herper J&J’s Mammen out of the running for Biogen CEO post by Adam Feuerstein, Matthew Herper, and Damian Garde Telehealth companies that prescribed controlled substances during the pandemic brace for business to change by Mohana Ravindranath and Katie Palmer Subscribe | 
No comments